Clinical Trial Update: Lidocaine Patch 1.8% for Moderate to Severe Pain From Carpal Tunnel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating lidocaine patch 1.8% for moderate to severe pain in carpal tunnel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carpal Tunnel Syndrome

Drugs mentioned

• lidocaine patch 1.8% (lidocaine 1.8% patch)

Snippet

Sponsor: John Papakonstantinou, MD | Conditions: Carpal Tunnel Syndrome | Phase 4 | Status: COMPLETED